PMLS Virtual Series 2021 – Pharmacogenomics & Pharmacovigilance in Precision Medicine

Pharmacovigilance and post-market surveillance are critical tools for following drug efficacy and safety in the general population after approval for therapeutic use.  Drug companies use data collected post-marketing to track number and type of adverse events as well as a host of clinical biomarkers.  Thanks to novel tests and high-throughput platforms, drug companies and regulatory agencies can gain better insights through more precise vigilance monitoring of clinical data and genetic information. By bringing to bear standard clinical tests with pharmacogenetic profiling, drug companies can better target patients most likely to respond to the therapy and improve the efficiency and efficacy of delivering drugs to patients.  Come join us to learn how pharmacogenetics can enhance pharmacovigilance by combining genetic and clinical data to focus precision medicine resources on clinical needs.

If you are a clinician, research scientist, or regulator, this conference is one you won’t want to miss. Please join us for the world’s most informative conference for precision pharmacogenomics and pharmacovigilance leaders with leaders from academia, biotech, pharmaceuticals, diagnostics, clinical research, healthcare and regulatory bodies.

We invite you to join us in for the Pharmacogenomics & Pharmacovigilance in Precision Medicine Virtual Summit with a line-up of speakers who will address these points and more:

• Clinical data in the era of precision medicine
• Genetics/Genomics Platforms
• Proteomics/Protein-based Assays
• The Economics of drug vigilance based on pharmacogenetics
• Positioning drugs tied to pharmacogenetics for coverage by payers
• Tracking and evaluating data through telehealth for rapid collections of vigilance data

Who should attend:

• Executives and Decision Makers – CEOs, CTOs, CMOs, and CSOs
• Leaders in clinical biostatistics
• Clinical trial planning and operations
• Clinical Research, Development, Translational Medicine
• Practicing Clinicians
• Genomics/Genetics Analysts
• Regulatory Leaders in Government and Business Affairs groups
• Economic Planners and Forecasters
• Marketing Leaders
• Business Development Managers
• Biotech and Biomedical technology researchers
• Government and public support agencies